<DOC>
	<DOCNO>NCT01518062</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial ass whether increase dos somatropin ( NorditropinÂ® ) maintain initial increase height velocity improve final height . This trial two trial period , main period 4 year extension period final height reach .</brief_summary>
	<brief_title>Safety Somatropin Induction Puberty With 17-beta-oestradiol Girls With Turner Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Turner Syndrome Well document growth rate previous year Height 50th percentile age Dutch child Normal thyroid function Any endocrine metabolic disorder Growth failure due disorder genitourinary , cardiopulmonary , gastrointestinal nervous system , nutritional/vitamins deficiency chondrodysplasias Patients hydrocephalus</criteria>
	<gender>Female</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>